Semin Respir Crit Care Med 2012; 33(01): 03-10
DOI: 10.1055/s-0032-1301729
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Hepatic Hydrothorax

Karen L. Krok
1   Department of Medicine, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania.
,
Andrés Cárdenas
2   Institute of Digestive Diseases and Metabolism, University of Barcelona, Hospital Clinic, Barcelona, Spain.
› Author Affiliations
Further Information

Publication History

Publication Date:
23 March 2012 (online)

Abstract

Hepatic hydrothorax is defined as a transudative pleural effusion, usually greater than 500 mL, in patients with portal hypertension without any other underlying primary cardiopulmonary cause. It develops most likely because of diaphragmatic defects that allow for passage of fluid from the peritoneal space to the pleural space. Because of the mechanical constraints of the thoracic cavity, this complication of portal hypertension can be challenging to treat because patients will become symptomatic when as little as 500 mL of fluid is present in the pleural space. Treatments include salt restriction, diuretics, thoracentesis, transjugular intrahepatic portosystemic shunt, video-assisted thoracoscopy, and pleurodesis. It is important to note that a chest tube is not a potential treatment option; a hepatic hydrothorax should not be treated with a chest tube unless there is frank pus in the pleural fluid or a pneumothorax is present. The ultimate treatment is a liver transplant; the development of a hepatic hydrothorax thus warrants a referral to a liver transplant center.

 
  • References

  • 1 Johnston RF, Loo RV. Hepatic hydrothorax; studies to determine the source of the fluid and report of thirteen cases. Ann Intern Med 1964; 61: 385-401
  • 2 Lieberman FL, Peters RL. Cirrhotic hydrothorax: further evidence that an acquired diaphragmatic defect is at fault. Arch Intern Med 1970; 125 (1) 114-117
  • 3 Esteve M, Xiol X, Fernadez F, González F, Baliellas C. Treatment and outcome of hydrothorax in liver cirrhosis. J Clin Nutr Gastroenterol 1986; 1: 139-144
  • 4 Giacobbe A, Facciorusso D, Barbano F, Andriulli A, Frusciante V. Hepatic hydrothorax: diagnosis and management. Clin Nucl Med 1996; 21 (1) 56-60
  • 5 Chen TA, Lo GH, Lai KH. Risk factors for spontaneous bacterial empyema in cirrhotic patients with hydrothorax. J Chin Med Assoc 2003; 66 (10) 579-586
  • 6 Lazaridis KN, Frank JW, Krowka MJ, Kamath PS. Hepatic hydrothorax: pathogenesis, diagnosis, and management. Am J Med 1999; 107 (3) 262-267
  • 7 Alagiakrishnan K, Patel PJ. Left-sided hepatic hydrothorax with ascites. Int J Clin Pract 1999; 53 (3) 225-226
  • 8 Lieberman FL, Hidemura R, Peters RL, Reynolds TB. Pathogenesis and treatment of hydrothorax complicating cirrhosis with ascites. Ann Intern Med 1966; 64 (2) 341-351
  • 9 Emerson PA, Davies JH. Hydrothorax complicating ascites. Lancet 1955; 268 (6862) 487-488
  • 10 Mouroux J, Perrin C, Venissac N, Blaive B, Richelme H. Management of pleural effusion of cirrhotic origin. Chest 1996; 109 (4) 1093-1096
  • 11 Chen A, Ho YS, Tu YC, Tang HS, Cheng TC. Diaphragmatic defect as a cause of massive hydrothorax in cirrhosis of liver. J Clin Gastroenterol 1988; 10 (6) 663-666
  • 12 Zenda T, Miyamoto S, Murata S, Mabuchi H. Detection of diaphragmatic defect as the cause of severe hepatic hydrothorax with magnetic resonance imaging. Am J Gastroenterol 1998; 93 (11) 2288-2289
  • 13 Huang PM, Chang YL, Yang CY, Lee YC. The morphology of diaphragmatic defects in hepatic hydrothorax: thoracoscopic finding. J Thorac Cardiovasc Surg 2005; 130 (1) 141-145
  • 14 Fathy O, Zeid MA, Abdallah T , et al. Laparoscopic cholecystectomy: a report on 2000 cases. Hepatogastroenterology 2003; 50 (52) 967-971
  • 15 Dawson R, Ferguson CJ. Life-threatening tension pneumothorax during laparoscopic cholecystectomy. Surg Laparosc Endosc 1997; 7 (3) 271-272
  • 16 Kinasewitz GT, Keddissi JI. Hepatic hydrothorax. Curr Opin Pulm Med 2003; 9 (4) 261-265
  • 17 Strauss RM, Boyer TD. Hepatic hydrothorax. Semin Liver Dis 1997; 17 (3) 227-232
  • 18 Alberts WM, Salem AJ, Solomon DA, Boyce G. Hepatic hydrothorax: cause and management. Arch Intern Med 1991; 151 (12) 2383-2388
  • 19 Jeffries MA, Kazanjian S, Wilson M, Punch J, Fontana RJ. Transjugular intrahepatic portosystemic shunts and liver transplantation in patients with refractory hepatic hydrothorax. Liver Transpl Surg 1998; 4 (5) 416-423
  • 20 Siegerstetter V, Deibert P, Ochs A, Olschewski M, Blum HE, Rössle M. Treatment of refractory hepatic hydrothorax with transjugular intrahepatic portosystemic shunt: long-term results in 40 patients. Eur J Gastroenterol Hepatol 2001; 13 (5) 529-534
  • 21 Xiol X, Castellote J, Cortes-Beut R, Delgado M, Guardiola J, Sesé E. Usefulness and complications of thoracentesis in cirrhotic patients. Am J Med 2001; 111 (1) 67-69
  • 22 Singer JA, Kaplan MM, Katz RL. Cirrhotic pleural effusion in the absence of ascites. Gastroenterology 1977; 73 (3) 575-577
  • 23 Rubinstein D, McInnes IE, Dudley FJ. Hepatic hydrothorax in the absence of clinical ascites: diagnosis and management. Gastroenterology 1985; 88 (1 Pt 1) 188-191
  • 24 Kirsch CM, Chui DW, Yenokida GG, Jensen WA, Bascom PB. Case report: hepatic hydrothorax without ascites. Am J Med Sci 1991; 302 (2) 103-106
  • 25 Benet A, Vidal F, Toda R, Siurana R, De Virgala CM, Richart C. Diagnosis of hepatic hydrothorax in the absence of ascites by intraperitoneal injection of 99m-Tc-Fluor colloid. Postgrad Med J 1992; 68 (796) 153
  • 26 Serena A, Aliaga L, Richter JA, Calderon R, Sanchez L, Charvet MA. Scintigraphic demonstration of a diaphragmatic defect as the cause of massive hydrothorax in cirrhosis. Eur J Nucl Med 1985; 11 (1) 46-48
  • 27 Kakizaki S, Katakai K, Yoshinaga T , et al. Hepatic hydrothorax in the absence of ascites. Liver 1998; 18 (3) 216-220
  • 28 Keddissi J, Eid AA, Janbey EM , et al. Incidence and outcome of hydrothorax in patients with chronic liver disease. Chest 2002; 122: 94S
  • 29 Xiol X, Guardiola J. Hepatic hydrothorax. Curr Opin Pulm Med 1998; 4 (4) 239-242
  • 30 Sese E, Xiol X, Castellote J, Rodríguez-Fariñas E, Tremosa G. Low complement levels and opsonic activity in hepatic hydrothorax: its relationship with spontaneous bacterial empyema. J Clin Gastroenterol 2003; 36 (1) 75-77
  • 31 Wang PS, Chen YM, Hsieh YL, Yu CF, Tsai CM, Perng RP. Pleural effusion and serum soluble fas-ligand levels are elevated in different clinical conditions. Lung 2002; 180 (1) 25-32
  • 32 Streifler J, Pitlik S, Dux S, Garty M, Rosenfeld JB. Spontaneous bacterial pleuritis in a patient with cirrhosis. Respiration 1984; 46 (4) 382-385
  • 33 Xiol X, Castellví JM, Guardiola J , et al. Spontaneous bacterial empyema in cirrhotic patients: a prospective study. Hepatology 1996; 23 (4) 719-723
  • 34 Conn HO, Fessel JM. Spontaneous bacterial peritonitis in cirrhosis: variations on a theme. Medicine (Baltimore) 1971; 50 (3) 161-197
  • 35 Almdal TP, Skinhøj P. Spontaneous bacterial peritonitis in cirrhosis: incidence, diagnosis, and prognosis. Scand J Gastroenterol 1987; 22 (3) 295-300
  • 36 Albillos A, Cuervas-Mons V, Millán I , et al. Ascitic fluid polymorphonuclear cell count and serum to ascites albumin gradient in the diagnosis of bacterial peritonitis. Gastroenterology 1990; 98 (1) 134-140
  • 37 Garcia-Tsao G. Spontaneous bacterial peritonitis. Gastroenterol Clin North Am 1992; 21 (1) 257-275
  • 38 Sort P, Navasa M, Arroyo V , et al. Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis. N Engl J Med 1999; 341 (6) 403-409
  • 39 Runyon BA, Greenblatt M, Ming RH. Hepatic hydrothorax is a relative contraindication to chest tube insertion. Am J Gastroenterol 1986; 81 (7) 566-567
  • 40 Orman ES, Lok AS. Outcomes of patients with chest tube insertion for hepatic hydrothorax. Hepatol Int 2009; 3 (4) 582-586
  • 41 Garcia Jr N, Mihas AA. Hepatic hydrothorax: pathophysiology, diagnosis, and management. J Clin Gastroenterol 2004; 38 (1) 52-58
  • 42 Runyon BA ; Practice Guidelines Committee, American Association for the Study of Liver Diseases (AASLD). Management of adult patients with ascites due to cirrhosis. Hepatology 2004; 39 (3) 841-856
  • 43 Moore KP, Wong F, Gines P , et al. The management of ascites in cirrhosis: report on the consensus conference of the International Ascites Club. Hepatology 2003; 38 (1) 258-266
  • 44 Ginès P, Cárdenas A, Arroyo V, Rodés J. Management of cirrhosis and ascites. N Engl J Med 2004; 350 (16) 1646-1654
  • 45 Sherman SC. Reexpansion pulmonary edema: a case report and review of the current literature. J Emerg Med 2003; 24 (1) 23-27
  • 46 McVay PA, Toy PT. Lack of increased bleeding after paracentesis and thoracentesis in patients with mild coagulation abnormalities. Transfusion 1991; 31 (2) 164-171
  • 47 Angueira CE, Kadakia SC. Effects of large-volume paracentesis on pulmonary function in patients with tense cirrhotic ascites. Hepatology 1994; 20 (4 Pt 1) 825-828
  • 48 Liu LU, Haddadin HA, Bodian CA , et al. Outcome analysis of cirrhotic patients undergoing chest tube placement. Chest 2004; 126 (1) 142-148
  • 49 Borchardt J, Smirnov A, Metchnik L, Malnick S. Treating hepatic hydrothorax. BMJ 2003; 326 (7392) 751-752
  • 50 Gordon FD, Anastopoulos HT, Crenshaw W , et al. The successful treatment of symptomatic, refractory hepatic hydrothorax with transjugular intrahepatic portosystemic shunt. Hepatology 1997; 25 (6) 1366-1369
  • 51 Strauss RM, Martin LG, Kaufman SL, Boyer TD. Transjugular intrahepatic portal systemic shunt for the management of symptomatic cirrhotic hydrothorax. Am J Gastroenterol 1994; 89 (9) 1520-1522
  • 52 Spencer EB, Cohen DT, Darcy MD. Safety and efficacy of transjugular intrahepatic portosystemic shunt creation for the treatment of hepatic hydrothorax. J Vasc Interv Radiol 2002; 13 (4) 385-390
  • 53 Conklin LD, Estrera AL, Weiner MA, Reardon PR, Reardon MJ. Transjugular intrahepatic portosystemic shunt for recurrent hepatic hydrothorax. Ann Thorac Surg 2000; 69 (2) 609-611
  • 54 Rössle M, Gerbes AL. TIPS for the treatment of refractory ascites, hepatorenal syndrome and hepatic hydrothorax: a critical update. Gut 2010; 59 (7) 988-1000
  • 55 Dhanasekaran R, West JK, Gonzales PC , et al. Transjugular intrahepatic portosystemic shunt for symptomatic refractory hepatic hydrothorax in patients with cirrhosis. Am J Gastroenterol 2010; 105 (3) 635-641
  • 56 Wilputte JY, Goffette P, Zech F, Godoy-Gepert A, Geubel A. The outcome after transjugular intrahepatic portosystemic shunt (TIPS) for hepatic hydrothorax is closely related to liver dysfunction: a long-term study in 28 patients. Acta Gastroenterol Belg 2007; 70 (1) 6-10
  • 57 Mouroux J, Hébuterne X, Perrin C , et al. Treatment of pleural effusion of cirrhotic origin by videothoracoscopy. Br J Surg 1994; 81 (4) 546-547
  • 58 Milanez de Campos JR, Filho LO, de Campos Werebe E , et al. Thoracoscopy and talc poudrage in the management of hepatic hydrothorax. Chest 2000; 118 (1) 13-17
  • 59 Falchuk KR, Jacoby I, Colucci WS, Rybak ME. Tetracycline-induced pleural symphysis for recurrent hydrothorax complicating cirrhosis: a new approach to treatment. Gastroenterology 1977; 72 (2) 319-321
  • 60 Ikard RW, Sawyers JL. Persistent hepatic hydrothorax after peritoneojugular shunt. Arch Surg 1980; 115 (9) 1125-1127
  • 61 Ferrante D, Arguedas MR, Cerfolio RJ, Collins BG, van Leeuwen DJ. Video-assisted thoracoscopic surgery with talc pleurodesis in the management of symptomatic hepatic hydrothorax. Am J Gastroenterol 2002; 97 (12) 3172-3175
  • 62 Takayama T, Kurokawa Y, Kaiwa Y , et al. A new technique of thoracoscopic pleurodesis for refractory hepatic hydrothorax. Surg Endosc 2004; 18 (1) 140-143
  • 63 Northup PG, Harmon RC, Pruett TL, Schenk III WG, Daniel TM, Berg CL. Mechanical pleurodesis aided by peritoneal drainage: procedure for hepatic hydrothorax. Ann Thorac Surg 2009; 87 (1) 245-250
  • 64 Drouhin F, Fischer D, Law Koune JD, Boiteau R, Tenaillon A, Labayle D. Treatment of hydrothorax in liver cirrhosis with chemical pleurodesis associated with continuous positive airway pressure ventilation: preliminary results [in French]. Gastroenterol Clin Biol 1991; 15 (3) 271-272